当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Imtiaj Hossain Chowdhury, SM Riajul Wahab, Ohidul Islam, Mahnaz Shiara, Fahim Faysal, Devaroti Bhattacherjee and Semanto Ray
Introduction: Ethnopharmacological relevance: Pilea microphylla is an important medicinal plant belonging to family Urticeaceae. This plant is used in traditional medicine to balance insulin levels and cure diabetes. This herb is beneficial in treating disorder related to breathing problem including asthma.
Aim of the study: The aim of the present study was to assess the in vivo anti-inflammatory activity and Antidiabetic activity of methanolic extracts of Pilea microphylla.
Materials and methods: The anti-inflammatory effect of the extracts was evaluated on paw edema in mice induced by carrageenan and the anti-diabetic activity was determined by oral glucose tolerance test (OGTT).
Results: In the present study the anti-inflammatory effect was observed of methanol extract in doses of 250 mg/kg and 500 mg/kg and the results were 74.18% and 72.17% inhibition of paw edema respectively compared to the standard drug Diclofenac-Na 80.42% inhibition of paw edema. The anti-diabetic effect was observed of methanol extract in doses of 250 mg/kg and 500 mg/kg and the results were 56.44% and 62.26% inhibition of paw edema respectively compared to the standard drug Metformin hydrochloride 78.05% inhibition of paw edema.
Conclusion: These findings suggest the use of Pilea microphylla as therapeutic agents to treat diabetes and inflammation as an alternative option of synthetic drugs particularly among poor people of developing countries.